A derivative of the natural compound kakuol affects DNA relaxation of topoisomerase IB inhibiting the cleavage reaction

被引:15
作者
Castelli, Silvia [1 ]
Vieira, Sara [1 ]
D'Annessa, Ilda [1 ]
Katkar, Prafulla [1 ]
Musso, Loana [2 ]
Dallavalle, Sabrina [2 ]
Desideri, Alessandro [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[2] Univ Milan, DeFENS Dept Food Environm & Nutr Sci, I-20133 Milan, Italy
关键词
Kakuol; Topoisomerase IB; Catalytic inhibitor; Cleavage; Docking; Natural compound; ANTICANCER DRUG; CRYSTAL-STRUCTURES; CAMPTOTHECIN; MECHANISM; DOMAIN; CYTOTOXICITY; CHEMOTHERAPY; FLEXIBILITY; SIMULATION; RESISTANCE;
D O I
10.1016/j.abb.2012.12.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Topoisomerases IB are anticancer and antimicrobial targets whose inhibition by several natural and synthetic compounds has been documented over the last three decades. Here we show that kakuol, a natural compound isolated from the rhizomes of Asarum sieboldii, and a derivative analogue are able to inhibit the DNA relaxation mediated by the human enzyme. The analogue is the most efficient one and the inhibitory effect is enhanced upon pre-incubation with the enzyme. Analysis of the different steps of the catalytic cycle indicates that the inhibition occurs at the cleavage level and does not prevent DNA binding. Molecular docking shows that the compound preferentially binds near the active site at the bottom of the catalytic residue Tyr723, providing an atomistic explanation for its inhibitory activity. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 43 条
[1]   Review of the use of topotecan in ovarian carcinoma [J].
Ahmad, T ;
Gore, M .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) :2333-2340
[2]   Targeting atypical trypanosomatid DNA topoisomerase I [J].
Balana-Fouce, Rafael ;
Redondo, Carmen M. ;
Perez-Pertejo, Yolanda ;
Diaz-Gonzalez, Rosario ;
Reguera, Rosa M. .
DRUG DISCOVERY TODAY, 2006, 11 (15-16) :733-740
[3]   Cytotoxic activity of some Asarum plants [J].
Cai, Shao-Qing ;
Yu, Jie ;
Wang, Xuan ;
Wang, Rui-Qing ;
Ran, Fu-Xiang ;
Shang, Ming-Ying ;
Cui, Jing-Rong ;
Komatsu, Katsuko ;
Namba, Tsuneo .
FITOTERAPIA, 2008, 79 (04) :293-297
[4]  
Castelli S., 2012, ANTICANCER AGENTS ME
[5]   Interaction between natural compounds and human topoisomerase I [J].
Castelli, Silvia ;
Coletta, Andrea ;
D'Annessa, Ilda ;
Fiorani, Paola ;
Tesauro, Cinzia ;
Desideri, Alessandro .
BIOLOGICAL CHEMISTRY, 2012, 393 (11) :1327-1340
[6]   Inhibition of human DNA topoisomerase IB by a Cyclometalated Gold III compound: Analysis on the different steps of the enzyme catalytic cycle [J].
Castelli, Silvia ;
Vassallo, Oscar ;
Katkar, Prafulla ;
Che, Chi-Ming ;
Sun, Raymond Wai-Yin ;
Desideri, Alessandro .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2011, 516 (02) :108-112
[7]   Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin [J].
Castelli, Silvia ;
Campagna, Alessia ;
Vassallo, Oscar ;
Tesauro, Cinzia ;
Fiorani, Paola ;
Tagliatesta, Pietro ;
Oteri, Francesco ;
Falconi, Mattia ;
Majumder, Hemanta I. ;
Desideri, Alessandro .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2009, 486 (02) :103-110
[8]   Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations [J].
Chillemi, Giovanni ;
D'Annessa, Ilda ;
Fiorani, Paola ;
Losasso, Carmen ;
Benedetti, Piero ;
Desideri, Alessandro .
NUCLEIC ACIDS RESEARCH, 2008, 36 (17) :5645-5651
[9]   The open state of human topoisomerase I as probed by molecular dynamics simulation [J].
Chillemi, Giovanni ;
Bruselles, Alessandro ;
Fiorani, Paola ;
Bueno, Susana ;
Desideri, Alessandro .
NUCLEIC ACIDS RESEARCH, 2007, 35 (09) :3032-3038
[10]  
Cho L Chinsoo, 2004, Oncology (Williston Park), V18, P29